THOMAS B. KING - 13 Dec 2023 Form 4 Insider Report for TFF Pharmaceuticals, Inc. (TFFP)

Role
Director
Signature
/s/ Thomas B. King
Issuer symbol
TFFP
Transactions as of
13 Dec 2023
Net transactions value
$0
Form type
4
Filing time
15 Dec 2023, 16:08:25 UTC
Previous filing
15 Dec 2023
Next filing
24 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TFFP Stock Options (Right to Buy) Award $0 +132,442 $0.000000 132,442 13 Dec 2023 Common Stock 132,442 $0.3500 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest and first become exercisable in 36 equal monthly installments, with the first installment vesting on December 13, 2024 and the remaining installments on the 13th of the month for the next 35 months.